Pfizer Inc.PFE
Closing prices as of Sep 15, 2026Updated once daily after the US close — not a live quote.

$27.54

+3.18% past month

Notable price movement

  • Sep 15, 2026

    $27.55-0.61%

    Pfizer shares slipped 0.61%, a decline consistent with comparable pharmaceutical companies, which fell 0.88% on average that day .

  • Sep 14, 2026

    $27.72+0.00%

    Pfizer shares were flat while comparable pharmaceutical companies rose 1.11% on average, meaning the day's move was not shared with peers .

  • Sep 11, 2026

    $27.72+0.25%

  • Sep 10, 2026

    $27.65-0.47%

    Comparable pharmaceutical companies fell 1.02% on average that day, with most names lower .

  • Sep 9, 2026

    $27.78-0.04%

  • Sep 8, 2026

    $27.79-2.32%

    Pfizer shares fell 2.32%, moving alongside comparable pharmaceutical companies, which dropped 2.55% on average with all six names in the group declining .

  • Sep 4, 2026

    $28.45-1.25%

    Pfizer shares fell 1.25%, a move consistent with its comparable pharmaceutical companies, which declined 1.51% on average the same day .

Closing prices for PFE. Summaries describe past sessions only and are not advice, a forecast or a recommendation.

Recent news

Seeking Alpha1 day agoUndervalued healthcare stocks with attractive valuation gradesThe Motley Fool1 day agoAlnylam's Sell-Off Looks Ugly -- but Wall Street Still Sees a Much Brighter Picture24/7 Wall StSep 7, 2026Forget the Dividend. This Could Be the Real Reason to Buy Pfizer Stock NowGlobenewswireAug 27, 2026Pfizer and BioNTech Receive U.S. FDA Approval for XFG-adapted COVID-19 VaccineSeeking Alpha1 day agoFDA launches pilot program that aims to speed the time to first-in-human drug trialsThe Motley Fool4 days agoHow Concerned Should Income Investors Be About Pfizer's Dividend?

Headlines are published by third parties and linked as reported. Amaltash does not endorse or verify them.

Prices and financial data are historical and provided for research only. Not investment advice.